Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- Check5 days agoChange DetectedAdded new help/navigation items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and included the current recruitment status notice, while removing a variant label (Intervention / Treatment) and updating the revision tag to v3.6.0.SummaryDifference0.2%

- Check13 days agoChange DetectedA new bibliographic citation regarding a publication comparing dupilumab and upadacitinib has been added to the study record. The revision tag has been updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, representing a small metadata-level update to the page without changing the displayed study information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Sweden location entry has been updated from Malmo to Malmö in Skåne County, Sweden, reflecting the correct city spelling in the study's location list.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now indicates a newer ClinicalTrials.gov site revision (“v3.5.3”) instead of the previous one (“v3.5.0”). This reflects a site/software version update rather than any change to the clinical study details.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.